Pharmaceutical Business Investment Opportunities in Thane

- Newly established pharmaceutical company, intending to manufacture hormones on third party/LL (Limited License) basis. - The company will run a dedicated facility to manufacture different hormonal formulations at large batch sizes. - In the process of setting up the manufacturing plant. - A majority of the set up has been concluded and only about 50% of the HVAC system is yet to be installed before the plant can be commissioned. - Have already installed several state-of-the-art machines and equipment to ensure high-quality production with minimal manual intervention. - The facility has custom manufacturing capabilities, a separate tablet and capsules section to prevent cross-contamination, blister and strip packing facilities, a micro-lab with MLT, a reference samples room and a stability room. - The facility also has classified clean rooms as per WHO-GMP and other regulatory standards. - The production unit is strategically located 2 hours from Mumbai and its building plan has been approved by MIDC. - Have also obtained MIDC approvals for power and water, Pre-FDA approval, consent to establish from MPCB and a NOC for a fire plant. - The facility will be a zero-waste facility with a negative carbon footprint due to the waste management systems and the advanced HVAC systems that incorporate AHU’s and Hepafilters. - The promoter has 20+ years of experience in the pharmaceutical industry and has already invested INR 5.3 crores into the development. - A thorough market analysis and market mapping exercise has been conducted and the business plan along with the financial projections are available for the investor to peruse. - Commercial operations are expected to be started within 4 months of securing the investment.

- Manufacturer of ready-to-fill pellets and directly compressible granules for tableting. - The unit is also engaged in developing new products like MUPS and modified release pellets. - The unit is set up in a 100,000 sq. ft. premises with all supporting facilities for manufacturing. - Company will be involved in the white labeling. - In talks with large domestic and international pharma companies and even Walmart. - Test run is done and they will soon commence production. - Family-owned general partnership with two owners having a 60:40 ownership pattern. - New entity with a bank loan of INR 21 crore. - The advisor handling this transaction is based in Mumbai, Maharashtra.